Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1227 (LINC01227) is a human long non-coding RNA (lncRNA) gene located in an intergenic genomic region, meaning it does not overlap with protein-coding genes [1][5]. Like other lincRNAs, it does not encode a protein but may regulate gene expression through epigenetic or transcriptional mechanisms, and may be involved in processes such as cell differentiation, cellular homeostasis, and regulation of signaling pathways [3]. While lincRNAs as a class have important roles in development, disease (including cancer and autoimmune diseases), and as potential diagnostic or prognostic markers, there is currently no direct evidence that LINC01227 is a validated therapeutic target, nor are there known disease associations, drug interactions, or biomarker use specifically attributed to LINC01227 [1][3][5].
Not applicable (no approved or known drugs targeting LINC01227)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1227 (LINC01227).